David Walde
Impact in
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Keyue Ding (5 shared papers)Malcolm J. Moore (3 shared papers)Daniel de Castro (2 shared papers)P. Murawa (2 shared papers)Robert Lim (2 shared papers)Arié Figer (2 shared papers)John Hamm (2 shared papers)David Goldstein (2 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Annals of Oncology (3 papers)Investigational New Drugs (2 papers)British Journal of Haematology (1 paper)Journal of Pain and Symptom Management (1 paper)
- Partner nations
- CanadaUnited StatesNew Zealand
In The Last Decade
David Walde
22 papers receiving 4.8k citations
David Walde's Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 3.3k
- Cancer Research 761
- Pulmonary and Respiratory Medicine 963
- Hepatology 189
- Surgery 658
Countries citing papers authored by David Walde
This map shows the geographic impact of David Walde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Walde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Walde more than expected).
Fields of papers citing papers by David Walde
This network shows the impact of papers produced by David Walde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Walde. The network helps show where David Walde may publish in the future.
Co-authors
The 25 scholars most cited alongside David Walde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group Hit paper breakdown → | 2007 | 3002 |
| 2 | Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study Hit paper breakdown → | 2001 | 919 |
| 3 | 2009 | 195 | |
| 4 | 1999 | 101 | |
| 5 | 1998 | 97 | |
| 6 | 1997 | 86 | |
| 7 | 2008 | 82 | |
| 8 | 2011 | 68 | |
| 9 | 2006 | 62 | |
| 10 | 1997 | 58 | |
| 11 | 2011 | 56 | |
| 12 | 2010 | 49 | |
| 13 | 2010 | 40 | |
| 14 | 1971 | 39 | |
| 15 | 1995 | 39 | |
| 16 | Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen. | 1995 | 32 |
| 17 | 2023 | 17 | |
| 18 | 2007 | 8 | |
| 19 | 1999 | 6 | |
| 20 | 1991 | 5 |
About David Walde
David Walde is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Genetics, having authored 22 papers that have together received 5.0k indexed citations. Recurring topics across this work include Nausea and vomiting management (5 papers), Lung Cancer Research Studies (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer Treatment and Pharmacology (3 papers), Estrogen and related hormone effects (2 papers), Lung Cancer Treatments and Mutations (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Opioid Use Disorder Treatment (1 paper). The work is most often cited by research in Oncology (3.3k citations), Cancer Research (761 citations), Pulmonary and Respiratory Medicine (963 citations), Hepatology (189 citations) and Surgery (658 citations). David Walde has collaborated with scholars based in Canada, United States and New Zealand. Frequent co-authors include Keyue Ding, Malcolm J. Moore, Daniel de Castro, P. Murawa, Robert Lim, Arié Figer, John Hamm, David Goldstein, Wendy R. Parulekar and J. Randolph Hecht. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Investigational New Drugs, British Journal of Haematology and Journal of Pain and Symptom Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.